Genome Canada and its partners recently funded two new initiatives with C$255 that will back precision medicine, genomics, and technology development.
Stat News reports that researchers are not good at predicting whether a clinical trial will be successful.
In a study of nearly 45,000 people, researchers found that two variants in LPA each increase aortic stenosis risk by about a third, and about twofold in combination.
A study of gene expression data from 173 breast cancer patients identified subtype-specific associations between molecular processes in tumor and blood cells.
A PLOS Biology study finds that cancer researchers tend to overestimate the extent to which preclinical studies may be reproducible.
In Nucleic Acids Research this week: MicrobiomeAnalyst, Cancer PanorOmics, and more
One speaker cited the success of screening Ashkenazi Jewish women for BRCA mutations, but another said extending testing to a wider population could be harder.
Researchers have released new tools for analyzing epigenomic data as part of the International Human Epigenome Consortium.
Using genotyping data, a McGill University-led team examined the ancestry and movements of African-American populations.
Nearly 8,000 patients participated in a screening study that used a PCR-based detection assay from Becton Dickinson, uncovering a 5 percent carrier rate.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.